We are live on ! Find out more
MCM

Mengis Capital Management Portfolio holdings

AUM $581M
1-Year Est. Return 28.04%
This Fund
S&P 500
This Quarter Est. Return
-0.13%
1 Year Est. Return
+28.04%
3 Year Est. Return
+72.9%
5 Year Est. Return
+105.39%
10 Year Est. Return
+334.2%
AUM
$479M
AUM Growth
-$10.6M
Cap. Flow
-$2.55M
Cap. Flow %
-0.53%
Top 10 Hldgs %
33.46%
Holding
195
New
7
Increased
52
Reduced
73
Closed
5

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$4.39M
2
PEP icon
PepsiCo
PEP
+$765K
3
HSY icon
Hershey
HSY
+$643K
4
BCD icon
abrdn Bloomberg All Commodity Longer Dated Strategy K-1 Free ETF
BCD
+$543K
5
AVGO icon
Broadcom
AVGO
+$335K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$3.67M
2
AAPL icon
Apple
AAPL
+$2.81M
3
MSFT icon
Microsoft
MSFT
+$1.57M
4
PCAR icon
PACCAR
PCAR
+$843K
5
WAT icon
Waters Corp
WAT
+$774K

Sector Composition

Rank Sector Weight
1 Technology 20.12%
2 Industrials 16.28%
3 Healthcare 13.72%
4 Consumer Staples 10.28%
5 Energy 7.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$34.9M 7.29%
157,180
-12,144
-7% -$2.81M
MSFT icon
2
Microsoft
MSFT
$2.84T
$25.1M 5.23%
66,766
-3,860
-5% -$1.57M
CVX icon
3
Chevron
CVX
$388B
$17.3M 3.6%
103,150
+202
+0.2% +$31.6K
JPM icon
4
JPMorgan Chase
JPM
$939B
$13.8M 2.88%
56,291
-704
-1% -$179K
PCAR icon
5
PACCAR
PCAR
$69.6B
$13M 2.71%
133,548
-7,994
-6% -$843K
DE icon
6
Deere & Co
DE
$170B
$12.8M 2.67%
27,290
– –
COST icon
7
Costco
COST
$415B
$12.1M 2.52%
12,777
-17
-0.1% -$16.6K
QCOM icon
8
Qualcomm
QCOM
$176B
$11M 2.29%
71,425
-78
-0.1% -$12.7K
GSIE icon
9
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.86B
$10.2M 2.13%
286,075
+5,833
+2% +$206K
GOOG icon
10
Alphabet (Google) Class C
GOOG
$3.9T
$10.2M 2.12%
65,073
-495
-0.8% -$90.6K
NVS icon
11
Novartis
NVS
$295B
$8.93M 1.86%
80,113
– –
PWR icon
12
Quanta Services
PWR
$93.9B
$8.88M 1.85%
34,936
+6
+0% +$1.73K
XOM icon
13
ExxonMobil
XOM
$651B
$8.35M 1.74%
70,240
-1,526
-2% -$169K
MDT icon
14
Medtronic
MDT
$107B
$8.27M 1.73%
91,979
+735
+0.8% +$65.8K
JNJ icon
15
Johnson & Johnson
JNJ
$635B
$7.72M 1.61%
46,524
-2,291
-5% -$358K
AMZN icon
16
Amazon
AMZN
$2.5T
$7.62M 1.59%
40,065
+140
+0.4% +$30.4K
PM icon
17
Philip Morris
PM
$301B
$7.04M 1.47%
44,382
-80
-0.2% -$11.3K
MRK icon
18
Merck
MRK
$324B
$6.09M 1.27%
67,869
-39,320
-37% -$3.67M
LLY icon
19
Eli Lilly
LLY
$1.07T
$6.06M 1.26%
7,334
-199
-3% -$166K
PEP icon
20
PepsiCo
PEP
$186B
$6.03M 1.26%
40,203
+5,142
+15% +$765K
HSY icon
21
Hershey
HSY
$35.4B
$5.3M 1.11%
30,992
+3,927
+15% +$643K
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.07T
$5.16M 1.08%
9,685
+30
+0.3% +$14.6K
MOAT icon
23
VanEck Morningstar Wide Moat ETF
MOAT
$11.5B
$5M 1.04%
56,815
+317
+0.6% +$29.2K
HUBB icon
24
Hubbell
HUBB
$25.7B
$4.63M 0.97%
14,000
– –
AZN icon
25
AstraZeneca
AZN
$263B
$4.46M 0.93%
+30,355
New +$4.39M
1
2 3 4 5

Similar funds

TCM
Trybe Capital Management Greenwich, Connecticut $581M AUM 112.96% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
TCMX
Technology Crossover Management XI Menlo Park, California $582M AUM 17.87% 1-Year Est. Return
DLCIG
D.L. Carlson Investment Group Concord, New Hampshire $582M AUM 29.47% 1-Year Est. Return
GF
Goodman Financial Houston, Texas $582M AUM 22.09% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Mengis Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Mengis Capital Management held 195 positions worth $479M, down 2.2% from $490M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Mengis Capital Management's Q1 2025 filing shows 7 new, 52 increased, 73 reduced and 5 closed positions. Its largest new stake was AstraZeneca: 30,355 shares worth $4.46M. The largest sale was Merck, an estimated $3.67M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Industrials and Healthcare.

  • Mengis Capital Management's largest Q1 2025 buy was AstraZeneca: 30,355 shares worth $4.46M.
  • Mengis Capital Management added most to PepsiCo in Q1 2025, an estimated $765K increase.
  • Mengis Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $3.67M.
  • Mengis Capital Management fully exited Visa in Q1 2025, selling an estimated $267K.
  • Mengis Capital Management's ten largest holdings make up 33% of its $479M portfolio in Q1 2025.
  • Mengis Capital Management opened 7 new positions and closed 5 in Q1 2025.
  • Mengis Capital Management's portfolio value fell 2.2% quarter-over-quarter to $479M.

Based on Mengis Capital Management's 13F filing for Q1 2025, filed 8 May 2025.